Lin TP - Search Results

1

Loss of MAOA in epithelia inhibits adenocarcinoma development, cell proliferation and cancer stem cells in prostate.

Liao CP, Lin TP, Li PC, Geary LA, Chen K, Vaikari VP, Wu JB, Lin CH, Gross ME, Shih JC. Liao CP, et al. Among authors: lin ch, lin tp. Oncogene. 2018 Sep;37(38):5175-5190. doi: 10.1038/s41388-018-0325-x. Epub 2018 May 29. Oncogene. 2018. PMID: 29844571 Free PMC article.

2

Monoamine oxidase A inhibitor-near-infrared dye conjugate reduces prostate tumor growth.

Wu JB, Lin TP, Gallagher JD, Kushal S, Chung LW, Zhau HE, Olenyuk BZ, Shih JC. Wu JB, et al. Among authors: lin tp. J Am Chem Soc. 2015 Feb 18;137(6):2366-74. doi: 10.1021/ja512613j. Epub 2015 Jan 27. J Am Chem Soc. 2015. PMID: 25585152

3

REST reduction is essential for hypoxia-induced neuroendocrine differentiation of prostate cancer cells by activating autophagy signaling.

Lin TP, Chang YT, Lee SY, Campbell M, Wang TC, Shen SH, Chung HJ, Chang YH, Chiu AW, Pan CC, Lin CH, Chu CY, Kung HJ, Cheng CY, Chang PC. Lin TP, et al. Among authors: lin ch. Oncotarget. 2016 May 3;7(18):26137-51. doi: 10.18632/oncotarget.8433. Oncotarget. 2016. PMID: 27034167 Free PMC article.

4

MAOA-Dependent Activation of Shh-IL6-RANKL Signaling Network Promotes Prostate Cancer Metastasis by Engaging Tumor-Stromal Cell Interactions.

Wu JB, Yin L, Shi C, Li Q, Duan P, Huang JM, Liu C, Wang F, Lewis M, Wang Y, Lin TP, Pan CC, Posadas EM, Zhau HE, Chung LWK. Wu JB, et al. Among authors: lin tp. Cancer Cell. 2017 Mar 13;31(3):368-382. doi: 10.1016/j.ccell.2017.02.003. Cancer Cell. 2017. PMID: 28292438 Free article.

5

MAOA-a novel decision maker of apoptosis and autophagy in hormone refractory neuroendocrine prostate cancer cells.

Lin YC, Chang YT, Campbell M, Lin TP, Pan CC, Lee HC, Shih JC, Chang PC. Lin YC, et al. Among authors: lin tp. Sci Rep. 2017 Apr 12;7:46338. doi: 10.1038/srep46338. Sci Rep. 2017. PMID: 28402333 Free PMC article.

6

HOTAIR is a REST-regulated lncRNA that promotes neuroendocrine differentiation in castration resistant prostate cancer.

Chang YT, Lin TP, Tang JT, Campbell M, Luo YL, Lu SY, Yang CP, Cheng TY, Chang CH, Liu TT, Lin CH, Kung HJ, Pan CC, Chang PC. Chang YT, et al. Among authors: lin ch, lin tp. Cancer Lett. 2018 Oct 1;433:43-52. doi: 10.1016/j.canlet.2018.06.029. Epub 2018 Jun 23. Cancer Lett. 2018. PMID: 29944905

7

R1 Regulates Prostate Tumor Growth and Progression By Transcriptional Suppression of the E3 Ligase HUWE1 to Stabilize c-Myc.

Lin TP, Li J, Li Q, Li X, Liu C, Zeng N, Huang JM, Chu GC, Lin CH, Zhau HE, Chung LWK, Wu BJ, Shih JC. Lin TP, et al. Among authors: lin ch. Mol Cancer Res. 2018 Dec;16(12):1940-1951. doi: 10.1158/1541-7786.MCR-16-0346. Epub 2018 Jul 24. Mol Cancer Res. 2018. PMID: 30042175 Free article.

8

Bidirectional Cross-talk between MAOA and AR Promotes Hormone-Dependent and Castration-Resistant Prostate Cancer.

Wei J, Yin L, Li J, Wang J, Pu T, Duan P, Lin TP, Gao AC, Wu BJ. Wei J, et al. Among authors: lin tp. Cancer Res. 2021 Aug 15;81(16):4275-4289. doi: 10.1158/0008-5472.CAN-21-0198. Epub 2021 Jun 24. Cancer Res. 2021. PMID: 34167949 Free PMC article.

9

Neuropilin-2 promotes lineage plasticity and progression to neuroendocrine prostate cancer.

Wang J, Li J, Yin L, Pu T, Wei J, Karthikeyan V, Lin TP, Gao AC, Wu BJ. Wang J, et al. Among authors: lin tp. Oncogene. 2022 Sep;41(37):4307-4317. doi: 10.1038/s41388-022-02437-0. Epub 2022 Aug 19. Oncogene. 2022. PMID: 35986103 Free PMC article.

10

Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

Powles T, Tomczak P, Park SH, Venugopal B, Ferguson T, Symeonides SN, Hajek J, Gurney H, Chang YH, Lee JL, Sarwar N, Thiery-Vuillemin A, Gross-Goupil M, Mahave M, Haas NB, Sawrycki P, Burgents JE, Xu L, Imai K, Quinn DI, Choueiri TK; KEYNOTE-564 Investigators. Powles T, et al. Lancet Oncol. 2022 Sep;23(9):1133-1144. doi: 10.1016/S1470-2045(22)00487-9. Lancet Oncol. 2022. PMID: 36055304 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

324 results

Search Page

Filters